Jaguar Health (JAGX) Receivables (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Receivables data on file, last reported at $280000.0 in Q1 2026.

• Receivables for Q1 2026 came in at $280000.0, down 79.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $280000.0 (down 79.84% YoY), and the FY2025 annual result was $1.7 million, up 3.1% from the prior year.
• Receivables fell to $280000.0 in Q1 2026 per JAGX's latest filing, from $1.7 million in the prior quarter.
• Over five years, Receivables peaked at $2.5 million in Q4 2022 and troughed at $280000.0 in Q1 2026.
• A 5-year average of $1.7 million and a median of $1.6 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2024 and 2026: Receivables grew 18.7% in 2024, then tumbled 79.84% in 2026.
• A 5-year view of Receivables shows it stood at $2.5 million in 2022, then dropped by 11.47% to $2.2 million in 2023, then declined by 24.59% to $1.6 million in 2024, then gained by 3.1% to $1.7 million in 2025, then sank by 83.51% to $280000.0 in 2026.
• Business Quant data shows JAGX's Receivables at $280000.0 in Q1 2026, $1.7 million in Q4 2025, and $1.5 million in Q3 2025.